- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11. | Glucotrack GAAP EPS of -$4.64 | 1 | Seeking Alpha | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 13.11. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | Glucotrack, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | Glucotrack sagt außerordentliche Hauptversammlung mangels Quorum ab | 2 | Investing.com Deutsch | ||
| 06.11. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.10. | Glucotrack, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 29.09. | GlucoTrack files to sell 20.06M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
| 29.09. | Glucotrack, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 15.09. | GlucoTrack stock tumbles after issuing $3.6M convertible note | 2 | Investing.com | ||
| 11.09. | Glucotrack, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 11.09. | Glucotrack, Inc.: Glucotrack to Participate in the Q3 Virtual Investor Summit | 3 | GlobeNewswire (USA) | ||
| 05.09. | Glucotrack, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 15.08. | Glucotrack GAAP EPS of -$9.62 | 1 | Seeking Alpha | ||
| 14.08. | Glucotrack to submit long-term CGM implant for FDA IDE this year | 1 | MassDevice | ||
| 14.08. | Glucotrack, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 14.08. | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | 312 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| 06.08. | Cardiac electrophysiologist Hirsh joins Glucotrack's clinical team | 1 | Investing.com | ||
| 06.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Glucotrack, Inc.: Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology | 207 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people... ► Artikel lesen |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,370 | -0,76 % | Wochenend-Analyse: Eckert&Ziegler-Aktie vor entscheidender Woche - Montag könnte alles ändern! | ||
| SERNOVA BIOTHERAPEUTICS | 0,088 | +6,06 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,018 | -12,50 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,097 | +3,74 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,218 | -2,68 % | Co-Diagnostics Reports Third Quarter 2025 Financial Results | SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company... ► Artikel lesen | |
| QUIDELORTHO | 24,600 | -0,81 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| VERU | 2,310 | +2,21 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 150,00 | -0,23 % | Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 | All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T programAcquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR- Antagonist, Phase 3-ready) and TPST-1495... ► Artikel lesen | |
| SENSEONICS | 5,350 | +1,90 % | XFRA 6L60: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| RADNET | 64,50 | -1,53 % | Raymond James reiterates Strong Buy rating on RadNet stock with $95 price target | ||
| NUWELLIS, INC | 2,210 | +2,31 % | Nuwellis, Inc.: Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum | MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing... ► Artikel lesen |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,71 % bei einem Aktienkurs von 4,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.